STROBE-based methodology for detection of adverse events across multiple communities
Related Experiment Video
Updated: Jun 28, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Margarita Sordo1, Judith Colecchi, Anil Dubey
1Massachusetts General Hospital, Partners Healthcare, Boston, MA, USA.
Abstract:
Partners Healthcare is one of five institutions in conjunction with eHealth Initiative (eHI) and the FDA that is collaborating in a nation-wide effort to develop novel health information technology tools to create an active drug safety surveillance system across the U.S. The STROBE statement serves as the standard for the definition of a structured, systematic, reproducible approach for detecting both the risks and benefits of drug treatments in multiple settings.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Investigation of Disease Outbreaks
Pulse Assessment Sites
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Principles of Disease Surveillance
Steps in Outbreak Investigation
